07:31 AM EDT, 05/09/2025 (MT Newswires) -- Kymera Therapeutics ( KYMR ) reported a Q1 net loss Friday of $0.82 per diluted share, widending from a $0.69 loss a year earlier.

Analysts polled by FactSet expected a loss of $0.88.

Collaboration revenue for the quarter ended March 31 was $22.1 million, compared with $10.3 million a year earlier.

Analysts polled by FactSet expected $10.7 million.

Kymera shares were up 1.6% in recent premarket activity.